All Industries

Top Drug Discovery Companies

1,077 Drug Discovery companies, sorted by total funding raised.

Scioto BiosciencesAcquired

Scioto is a preclinical stage company developing innovative therapies devoted to having a transfo...

Indianapolis, United States1–10Biotech, Drug Discovery
Series BTotal funding$30.6MAug 2020
Converge Bio

Generative AI platform for accelerated drug discovery and molecule design serving pharma and biot...

Tel Aviv, Israel11–50Artificial Intelligence, Biotech
Series ATotal funding$30.5MJan 2025
FOX CHASE CHEMICAL DIVERSITY CENTER INC.

R&D company with 29 SBIR/STTR awards from Department of Health and Human Services.

DOYLESTOWN, United States11–50Biotech, Drug Discovery
GrantTotal funding$30.5MAug 2024
BC Platforms

BC Platforms provides healthcare and life-sciences organizations with federated data technology, ...

Zurich, SwitzerlandAnalytics, Drug Discovery
Growth EquityTotal funding$30.0MNov 2022
Form Bio

AI-driven platform for designing and optimizing genetic medicines and genome engineering for biot...

Austin, United States11–50Artificial Intelligence, Biotech
Series ATotal funding$30.0MSep 2022
MerLion Pharma
Biotech, Drug Discovery
Growth EquityTotal funding$30.0MMay 2021
US WorldMeds

US WorldMeds is a specialty pharmaceutical company that licenses, develops, and delivers medicine...

Louisville, United StatesDrug Discovery, Healthcare
Venture RoundTotal funding$30.0MApr 2018
VIEWPOINT MOLECULAR TARGETING, INC.Acquired

R&D company with 11 SBIR/STTR awards from Department of Health and Human Services.

CORALVILLE, United States11–50Biotech, Healthcare
GrantTotal funding$29.9MJun 2024
Great Bay Bio 大湾生物

By utilizing AI and other cutting-edge technologies, GBB aims to address the challenges of long t...

Hong Kong, China51–200Artificial Intelligence, Biotech
Series BTotal funding$28.8MDec 2024
Adimab

Provides antibody discovery and engineering services to biopharma partners using a yeast-based pl...

Lebanon, United States51–200Biotech, Drug Discovery
Series FTotal funding$26.0MJan 2012
Commit Biologics

Commit Biologics is a biotech spin-out from Aarhus University founded in 2021. The Commit team co...

Biotech, Drug Discovery
Extension RoundTotal funding$25.1MJan 2025
NUVISAN GmbH
Drug Discovery, Healthcare
GrantTotal funding$25.0MJun 2026
Talus Bio

Talus Bio measures and modulates the regulome in its native context and partners with teams devel...

Seattle, United States11–50Biotech, Drug Discovery
Venture RoundTotal funding$24.7MAug 2024
Iterion Therapeutics

Iterion Therapeutics develops Tegavivint, a small-molecule inhibitor targeting the Wnt/beta-caten...

Biotech, Drug Discovery
GrantTotal funding$24.1MNov 2025
Dignify Therapeutics LLC

R&D company with 20 SBIR/STTR awards from Department of Health and Human Services.

Research Triangle Park, United States1–10Biotech, Healthcare
GrantTotal funding$24.1MSep 2024
Appello Pharmaceuticals
Biotech, Drug Discovery
Series ATotal funding$24.0MJun 2018
PostEra

Medicinal Chemistry powered by Machine Learning

Boston, United States11–50Drug Discovery, Healthcare
Series ATotal funding$24.0MJan 2022
Sibylla Biotech

Drug discovery platform to unveil a new class of small-molecule degraders

Artificial Intelligence, Biotech
Series ATotal funding$22.6MOct 2022
1910 Genetics

Make undruggable targets a thing of the past

Mountain View, United States11–50Drug Discovery, Healthcare
GrantTotal funding$22.5MJul 2021
Paradigm Spine
Drug Discovery, Healthcare
Venture RoundTotal funding$20.4MJul 2009
Archon Biosciences

Biotechnology company developing AI-designed Antibody Cages (AbCs), a novel class of biologics th...

Seattle, United States11–50Biotech, Drug Discovery
SeedTotal funding$20.0MNov 2024
Creyon

AI-driven drug development company creating tissue-specific RNA-targeted oligonucleotide medicines.

San Diego, United States11–50Artificial Intelligence, Biotech
SeedTotal funding$20.0MMar 2022
Spinal Simplicity
Drug Discovery, Healthcare
Growth EquityTotal funding$20.0M
Sprout Pharmaceuticals
Biotech, Drug Discovery
Venture RoundTotal funding$20.0MSep 2019
ThirtyFiveBio Limited

Biotechnology company developing first-in-class small molecule GPR35 inhibitors to treat ulcerati...

United KingdomBiotech, Drug Discovery
BridgeTotal funding$20.0MApr 2025